SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-001450
Filing Date
2017-03-13
Accepted
2017-03-13 08:53:15
Documents
24
Period of Report
2017-03-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031317.htm 8-K 13773
2 EXHIBIT 99.1 exh_991.htm EX-99.1 38191
3 GRAPHIC image_001.jpg GRAPHIC 193396
4 GRAPHIC image_002.jpg GRAPHIC 298394
5 GRAPHIC image_003.jpg GRAPHIC 362226
6 GRAPHIC image_004.jpg GRAPHIC 213252
7 GRAPHIC image_005.jpg GRAPHIC 245856
8 GRAPHIC image_006.jpg GRAPHIC 194987
9 GRAPHIC image_007.jpg GRAPHIC 211552
10 GRAPHIC image_008.jpg GRAPHIC 147040
11 GRAPHIC image_009.jpg GRAPHIC 286749
12 GRAPHIC image_010.jpg GRAPHIC 264350
13 GRAPHIC image_011.jpg GRAPHIC 261259
14 GRAPHIC image_012.jpg GRAPHIC 238182
15 GRAPHIC image_013.jpg GRAPHIC 239851
16 GRAPHIC image_014.jpg GRAPHIC 146026
17 GRAPHIC image_015.jpg GRAPHIC 277789
18 GRAPHIC image_016.jpg GRAPHIC 153757
19 GRAPHIC image_017.jpg GRAPHIC 260195
20 GRAPHIC image_018.jpg GRAPHIC 197289
21 GRAPHIC image_019.jpg GRAPHIC 374657
22 GRAPHIC image_020.jpg GRAPHIC 152960
23 GRAPHIC image_021.jpg GRAPHIC 239281
24 GRAPHIC image_022.jpg GRAPHIC 238257
  Complete submission text file 0001171843-17-001450.txt   7213329
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 17684114
SIC: 2834 Pharmaceutical Preparations